Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Particle Works offers bespoke microencapsulation for drug development

Particle Works
Posted on: 11 Oct 16
Particle Works offers bespoke microencapsulation for drug development

Particle Works – the nano- and microstructured material specialist – provides microencapsulation services for drug development applications, including controlled drug release, solubility enhancement or targeted drug delivery. Using its expertise in microfluidics and nanoparticle synthesis, the company can create bespoke PLGA formulations and coatings to alter drug release profiles, enhance the efficiency of targeted drug delivery and more precisely control dosing regimes.

Microencapsulation of active pharmaceutical ingredients (APIs) is increasingly being employed in the drug development arena to improve the solubility of candidate drugs or protect biopharmaceutical agents (DNA, proteins, etc) from degradation, as well as to provide more controlled release of APIs over time. Functionalization of the particle surfaces with specific binding species – such as antibodies, aptamers and peptides – also allows the particles to be targeted to a specific location or tissue, increasing the efficacy of many drugs. PLGA is commonly used for drug microencapsulation, and precise control over particle size, shape and architecture is extremely important to the efficacy of the candidate drug. Particle Works can use its expertise in nanoparticle development to improve the targeting efficiency, distribution and lifetime of the particles in vivo. From the encapsulation of candidate APIs in custom PLGA configurations to the creation of unique functionalized coatings, the company can provide high quality development and scale-up of highly monodisperse nanoparticles (typical CV values of <5 %) offering improved targeting efficiency, efficacy and reproducibility.

For more information, visit: http://www.particle-works.com/applications/targeted-drug-delivery/

 
About Particle Works

Particle Works manufactures high-performance nano- and microstructured materials with precisely controlled particle size, shape and architecture. Particle Works is a brand of Blacktrace Holdings Ltd (www.blacktrace.com), a world leader in Productizing Science®. Our Head Office is based in Royston (near Cambridge), UK and we have regional offices in the USA, Japan, India and Brazil. Our range of products include Metal Nanoparticles (Gold and Cobalt Nanoparticles), Quantum Dots,

Hydrogels (Alginate Beads) and PLGA Beads (custom microencapsulations) suitable for  use in many applications such as lateral flow assays, bioimaging, targeted drug delivery, cell growth etc. To find out more about Particle Works, please visit: www.particle-works.com.

Editor's Details

kdm communications ltd
kdm communications ltd
www.kdm-communications.com
ideas@kdm-communications.com

Last updated on: 11/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.